The company also announced its revenue for the year ended Dec. 31, 2013 — $685.17 million — up from the year ended Dec. 31, 2012, which resulted in revenues of $620.25 million.
NuVasive reported a net income of around $6 million in the fourth quarter of FY 2013 as compared to the net loss of $2.74 million it suffered during the same period last year. For the year ended Dec. 31, 2013, the company recorded a net income $7.9 million, up from the same period last year, reported as $3.1 million.
NuVasive is focused on developing minimally invasive solutions, such as its Maximum Access Surgery or MAS platform for lateral spine fusion and the PCM motion preserving disc for the cervical spine.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
